Basics of Chimeric Antigen Receptor (CAR) Immunotherapy
eBook - ePub

Basics of Chimeric Antigen Receptor (CAR) Immunotherapy

  1. 92 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Basics of Chimeric Antigen Receptor (CAR) Immunotherapy

About this book

Basics of Chimeric Antigen Receptor (CAR) Immunotherapy presents the latest on how T cell adoptive immunotherapy has progressed in its ultimate goal of curing metastatic malignant cancers. Recent clinical data obtained with checkpoint receptor blockade inhibitors and chimeric antigen receptor (CAR) therapy has been especially promising, thus generating renewed hope that we may be on the verge of finally curing cancer. Over the years, huge progress has been made in controlling several stage IV metastasized cancers through the clinical application of checkpoint receptor inhibitory drugs and CAR-Therapy that has seen unprecedented interest in the immunotherapy field.- Presents the first book to provide a basic understanding of chimeric antigen receptor (CARs) design, production and clinical application protocols- Provides unique authority as the editor has worked directly with CARs- Discusses the challenges encountered in actual clinical trials and how these challenges can be overcome- Includes a full chapter on various challenges researchers should expect to encounter in the CAR-therapy field

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Basics of Chimeric Antigen Receptor (CAR) Immunotherapy by Mumtaz Y. Balkhi in PDF and/or ePUB format, as well as other popular books in Medicine & Immunology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
Academic Press
Year
2019
Print ISBN
9780128195734
eBook ISBN
9780128197479
Topic
Medicine
Subtopic
Immunology

Table of contents

  1. Cover image
  2. Title page
  3. Table of Contents
  4. Copyright
  5. Preface
  6. Chapter 1. An Introduction to CAR Immunotherapy
  7. Chapter 2. Components and Design of Chimeric Antigen Receptors
  8. Chapter 3. scFv Cloning, Vectors, and CAR-T Production in Laboratory for Preclinical Applications
  9. Chapter 4. Production of CAR-T Cells for Clinical Applications
  10. Chapter 5. Challenges and Opportunities to Improve CAR T-Cell Therapy
  11. Index